Skip to content

Activity and Recreation in Communities for Health

Activity and Recreation in Communities for Health (ARCH) - Pilot Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06093282
Acronym
ARCH
Enrollment
102
Registered
2023-10-23
Start date
2024-09-01
Completion date
2026-08-31
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

This project tests whether a health outreach intervention that promotes engagement in rewarding, community-based recreational and social activities can produce greater improvements in depressive symptoms, adiposity, and physical activity among people from underresourced communities than traditional health outreach approaches.

Detailed description

Underresourced communities are affected by structural barriers and detrimental conditions that contribute to disparities in mental and physical health. People living in these communities may also face financial and logistical barriers to engaging in meaningful and rewarding activities in their community, which is linked to risk for depression and cardiometabolic disease in emerging health behavior models. There is also evidence that depression, physical inactivity, and reward-driven overeating exhibit reciprocal causal relationships that promote cardiometabolic disease through multiple pathways, which supports the value of intervening on these co-occurring risk factors simultaneously. Structured interventions that increase engagement in rewarding activities are effective for treating depression, but this approach has not been adapted for broad dissemination in underresourced populations that face challenges accessing the health care system, and have a high burden of cardiometabolic risk factors. This project will refine and test a novel approach for reducing the burden of depression and cardiometabolic disease in underresourced communities. The Activity and Recreation in Communities for Health (ARCH) intervention is designed to promote engagement in rewarding activities through an adaptation of Behavioral Activation Treatment for Depression, and direct provision of resources to engage in rewarding recreational and social activities both independently and through our partnering community-based organizations. ARCH is designed to be delivered in participants' homes and community venues by a health outreach workforce, which addresses barriers to accessing treatment. Aim 1 is to engage community stakeholders in the process of co-designing ARCH to maximize feasibility, acceptability, and uptake. Aim 2 is to conduct an initial evaluation of the refined ARCH intervention among adults from underresourced communities with depression. Changes in depressive symptoms, adiposity, and physical activity over four months will be compared between those randomly assigned to ARCH versus a traditional health outreach comparator. In addition to clinical outcomes, key metrics of program uptake, cost, and feasibility will be quantified, and hypothesized mechanisms underlying treatment effects will be explored (Aim 3). Findings will inform the design of a definitive implementation trial, and determine the potential value of incorporating behavioral activation in other outreach interventions for underserved populations

Interventions

BEHAVIORALARCH

ARCH is a 4-month health outreach intervention that includes the following components: * Screening and referral to address social determinants of health * A 12-session adaptation of Behavioral Activation Treatment for Depression * Weekly contacts from an outreach worker * Optional resources aimed at promoting physical activity and weight management

BEHAVIORALTraditional Health Outreach

The Traditional Health Outreach comparator is a 4-month health outreach intervention that includes the following components: * Screening and referral to address social determinants of health * Support calls from an outreach worker at least once every 3 weeks

Sponsors

Rush University Medical Center
Lead SponsorOTHER
University of Chicago
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Outcomes assessors and the Investigators are blinded to individual participants' treatment assignment.

Intervention model description

Two-arm, parallel group design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Member of an underserved population defined by either of the following: 1. Received health care at a federally qualified health center within the past 2 years 2. Living in a neighborhood with an Area Deprivation Index ≤ 20th percentile 2. Elevated depressive symptoms (10-item CES-D score≥10)94,95 3. One or both of the following modifiable cardiometabolic risk factors: 1. Excess adiposity (body mass index ≥ 28.0 kg/m2) 2. Physically inactive according to the 2018 U.S. Physical Activity Guidelines:96 less than 150 minutes of moderate intensity, 75 minutes of vigorous intensity, or an equivalent combination of moderate and vigorous intensity activity, per week based on a 7-day accelerometry protocol

Exclusion criteria

1. Under 18 years of age 2. Not fluent in English 3. Uncontrolled serious mental illness 4. High risk for suicidality on the Columbia Suicide Severity Scale 5. Conditions jeopardizing staff safety at home data visits 6. Individual is dependent on a caretaker for activities of daily living 7. Currently lives or plans to move outside Cook and Lake Counties

Design outcomes

Primary

MeasureTime frameDescription
Depressive symptoms4 monthsChange in depressive symptoms on the 10-item version of the Centers for Epidemiological Studies - Depression Scale (CES-D-10)

Secondary

MeasureTime frameDescription
Physical activity4 monthsChange in daily minutes of moderate-vigorous physical activity measured by accelerometer
Weight loss4 monthsWeight change will be calculated as a percentage of baseline weight

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026